Johnson & Johnson has a high three-year median payout ratio of 71% (or a retention ratio of 29%), meaning that the company is ...

The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999. Since ...

On Friday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $155.47 which represents a decrease of $-1.26 or -0.80% from the prior close of $156.73. The stock opened at $157 and touched ...

Johnson & Johnson (JNJ), with a market cap of $377.3 billion, is a leading healthcare company based in New Brunswick, New ...

Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration has approved the Ottava robotic surgical system ...

On Tuesday, Johnson & Johnson (JNJ) stock saw a modest uptick, ending the day at $158.35 which represents a slight increase of $0.11 or 0.07% from the prior close of $158.24. The stock opened at $157.

In my view, such adjustments are totally acceptable, and I shared my reasons - although obviously not directly comparable - ...

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...

Julian Harrison gave his rating based on several factors surrounding Protagonist Therapeutics’ promising drug candidate, JNJ-2113. The upcoming Phase 3 trial data for JNJ-2113 in psoriasis is pivotal, ...

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...

Raritan: Johnson & Johnson has announced the submission of regulatory applications to the U.S. Food and Drug Administration ...

FMCCH Federal Home Loan Mortgage Corporation 12.57 +5.84 (+86.78%) FMCKL Federal Home Loan Mortgage Corporation 6.82 +3.11 (+83.16%) FMCCM Federal Home Loan Mortgage Corporation 12.81 +5.81 (+83. ...